NEBCIN
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Jun 1975
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NEBCIN is an injectable small-molecule antibiotic approved by FDA in 1975 as an NDA from Eli Lilly. The drug's specific mechanism of action and approved indications are not publicly detailed in available data, but injectable antibiotics of this era typically target bacterial infections. The product is approaching loss of exclusivity, indicating decades of market presence and likely generic competition.
LOE Approaching
With LOE approaching and no linked jobs currently available, this legacy product likely operates with a small, maintenance-focused team managing decline rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
NEBCIN offers minimal active career opportunities with zero linked jobs currently available. Professionals assigned to this product are typically in maintenance and risk-mitigation roles rather than growth or innovation tracks, limiting long-term career advancement potential within the commercial pharmaceutical space.
Supply Chain ManagerCompliance Officer
Worked on NEBCIN at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.